Value of Preoperative Ultrasonography in the Surgical Management of Initial and Reoperative Papillary Thyroid Cancer | Endocrine Surgery | JAMA Surgery | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.207.129.82. Please contact the publisher to request reinstatement.
1.
Hay  IDGrant  CSTaylor  WFMcConahey  WM Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system.  Surgery 1987;1021088- 1095PubMedGoogle Scholar
2.
Mazzaferri  ELJhiang  DM Long-term impact of initial surgical and medical therapy of papillary and follicular thyroid cancer.  Am J Med 1994;97418- 428PubMedGoogle ScholarCrossref
3.
Hay  IDThompson  GBGrant  CS  et al.  Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients.  World J Surg 2002;26879- 885PubMedGoogle ScholarCrossref
4.
Grant  CSHay  IDGough  IRBergstralh  EJGoellner  JRMcConahey  WM Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important?  Surgery 1988;104954- 962PubMedGoogle Scholar
5.
Cady  BRossi  R An expanded view of risk-group definition in differentiated thyroid carcinoma.  Surgery 1988;104947- 953PubMedGoogle Scholar
6.
Schlumberger  MJ Papillary and follicular thyroid carcinoma.  N Engl J Med 1998;338297- 306PubMedGoogle ScholarCrossref
7.
Noguchi  SMurakami  N The value of lymph-node dissection in patients with differentiated thyroid cancer.  Surg Clin North Am 1987;67251- 261PubMedGoogle Scholar
8.
Ozaki  OKunihiko  IKobayashi  KSuzuki  AManabe  Y Modified neck dissection for patients with nonadvanced, differentiated carcinoma of the thyroid.  World J Surg 1988;12825- 829PubMedGoogle ScholarCrossref
9.
Singer  PACooper  DSDaniels  GH Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer.  Arch Intern Med 1996;1562165- 2172PubMedGoogle ScholarCrossref
10.
Thyroid Carcinoma Task Force, AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma: American Association of Clinical Endocrinologists: American College of Endocrinology.  Endocr Pract 2001;7203- 220Google Scholar
11.
Mazzaferri  ELYoung  RLOertel  JEKemmerer  WTPage  CP Papillary thyroid carcinoma: the impact of therapy in 576 patients.  Medicine (Baltimore) 1977;56171- 196PubMedGoogle ScholarCrossref
12.
Kouvaraki  MAShapiro  SEFornage  BD  et al.  Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer.  Surgery 2003;134946- 955PubMedGoogle ScholarCrossref
13.
Simeone  JFDaniels  GHHall  DA  et al.  Sonography in the follow-up of 100 patients with thyroid carcinoma.  AJR Am J Roentgenol 1987;14845- 49PubMedGoogle ScholarCrossref
14.
Kouvaraki  MALee  JEShapiro  SESherman  SIEvans  DB Preventable reoperations for persistent and recurrent papillary thyroid carcinoma.  Surgery 2004;1361183- 1191Google ScholarCrossref
15.
Mazzaferri  ELRobbins  RJSpencer  CA  et al.  A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.  J Clin Endocrinol Metab 2003;881433- 1441PubMedGoogle ScholarCrossref
16.
Duren  MSiperstein  AShen  WDuh  Q-YMorita  EClark  O Value of stimulated serum thyroglobulin levels for detecting persistent or recurrent differentiated thyroid cancer in high- and low-risk patients.  Surgery 1999;12613- 19PubMedGoogle ScholarCrossref
17.
Haugen  BRRidgway  ECMcLaughlin  BAMcDermott  MT Clinical comparison of whole-body radioiodine scan and serum thyroglobulin after stimulation with recombinant human thyrotropin.  Thyroid 2002;1237- 43PubMedGoogle ScholarCrossref
18.
Greene  FPage  DFleming  IFritz  ABalch  CHaller  DG AJCC Cancer Staging Manual. 6th ed. New York, NY Springer-Verlag NY Inc2002;
19.
Ladenson  PWEwertz  MEDickey  RA Practical application of recombinant thyrotropin testing in clinical practice.  Endocr Pract 2001;7195- 201PubMedGoogle ScholarCrossref
20.
Eustatia-Rutten  CFSmit  JWRomijn  JA  et al.  Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis.  Clin Endocrinol (Oxf) 2004;6161- 74PubMedGoogle ScholarCrossref
Paper
May 1, 2006

Value of Preoperative Ultrasonography in the Surgical Management of Initial and Reoperative Papillary Thyroid Cancer

Author Affiliations

Author Affiliations: Departments of Gastrointestinal and General Surgery (Drs Stulak, Grant, Farley, Thompson, and van Heerden), Endocrinology (Dr Hay), and Diagnostic Radiology (Dr Reading and Mr Charboneau), Mayo Clinic College of Medicine, Rochester, Minn.

Arch Surg. 2006;141(5):489-496. doi:10.1001/archsurg.141.5.489
Abstract

Background  Cervical recurrences, predominantly in lymph nodes, occur in 14% to 30% of patients with papillary thyroid cancer (PTC). Postoperative surveillance for recurrent PTC increasingly includes thyrotropin-stimulated thyroglobulin and high-resolution ultrasonography (US). This combination commonly can detect recurrent disease as small as 5 mm.

Hypothesis  Preoperative US will increase detection and assessment of the extent of lymph node metastasis (LNM) in patients with PTC.

Design  Retrospective cohort study.

Setting  Tertiary care academic center.

Patients  From January 1, 1999, to December 31, 2004, a total of 770 patients were seen, 551 (381 female and 170 male; median age, 47 years; age range, 9-89 years) who underwent initial surgical management and 219 (154 female and 65 male; median age, 44 years; age range, 5-90 years) who underwent cervical reoperation for PTC. The US images were obtained preoperatively for 486 initial and 216 reoperative patients. Therapeutic radioactive iodine was administered to 151 (68.9%) of the reoperative patients before the subsequent operation (median dose, 5.6 × 109 Bq; range, 7.4 × 108-3.7 × 1010 Bq).

Results  Ultrasonography identified nonpalpable lateral jugular LNMs in 70 (14.4%) of the patients undergoing initial exploration. Similarly, in reoperative patients, nonpalpable lateral LNMs were detected via US in 106 (64.2%), and 61 (28.2%) had LNMs detected in the central neck. Even when nodes were palpable preoperatively (37 [6.7%] of the initial and 56 [25.6%] of the reoperative patients), US assessment of the extent of LNM involvement altered the operation in 15 (40.5%) of the initial and 24 (42.9%) of the reoperative patients. The sensitivity, specificity, and positive predictive value for US were 83.5%, 97.7%, and 88.8% in initial patients, and 90.4%, 78.9%, and 93.9% in reoperative patients.

Conclusions  Overall, preoperative US detected nonpalpable LNMs in 231 (32.9%) of the 702 patients with PTC who underwent US, thereby altering the operative procedure performed. In addition, even in patients with palpable LNs, US helped to guide the extent of lymphadenectomy.

×